Author
1. Wander Gurpreet S
2. Nair Tiny
3. Bahl VK
4. Bhasin Dinkar
ISBN
9789390020683
DOI
10.5005/jp/books/18355_9
Edition
1/e
Publishing Year
2020
Pages
2
Author Affiliations
1.
Dayanand Medical College and Hospital, Hero DMC Heart Institute, Ludhiana, Punjab, India,
Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India,
Unit Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India,
Dayanand Medical College and Hospital, Unit-Hero DMC Heart Institute, Ludhiana, Punjab, India,
Unit Hero DMC Heart Institute, Ludhiana, Punjab, India,
Dayanand Medical College and Hospital Ludhiana, Punjab, India,
API
2.
PRS Hospital, Karamana, Trivandrum, Kerala, India,
PRS Hospital, Thiruvananthapuram, Kerala, India,
P Ratnaswamy Hospital, Thiruvananthapuram, Kerala, India,
PRS Hospital, Trivandrum, Kerala, India
3.
AIIMS, New Delhi, India,
AIIMS, New Delhi, India; National CSI,
All India Institute of Medical Sciences, New Delhi, India,
Max Health Care; All India Institute of Medical Sciences, New Delhi, India,
Max Superspeciality Hospital, Patparganj, New Delhi, India
4.
All India Institute of Medical Sciences, New Delhi, India,
Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India,
Vardhman Mahavir Medical College and afdarjung Hospital and New Delhi, India,
Vardhman Mahavir Medical College and Safdarjung Hospital and New Delhi, India
Chapter keywords
Dapagliflozin,
heart failure,
reduced ejection fraction,
type 2 diabetes mellitus,
T2DM,
sodium-glucose cotransporter-2,
SGLT-2,
hazard ratio,
confidence interval,
CI,
cardiovascular cause,
angiotensin-receptor neprilysin inhibitor,
ARNI